OPKO HEALTH INCOPKO HEALTH INCOPKO HEALTH INC

OPKO HEALTH INC

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪1.05 B‬EUR
−0.16EUR
‪−171.11 M‬EUR
‪782.34 M‬EUR
‪318.71 M‬
Beta (1Y)
1.21
Employees (FY)
‪3.93 K‬
Change (1Y)
−266 −6.34%
Revenue / Employee (1Y)
‪219.72 K‬EUR
Net income / Employee (1Y)
‪−48.06 K‬EUR

About Opko Health, Inc.


CEO
Phillip Frost
Website
Headquarters
Miami
Founded
1991
FIGI
BBG000KXLBP9
OPKO Health, Inc. is a biopharmaceutical and diagnostics company, which engages in the provision of healthcare services. It operates through the following segments: Diagnostics and Pharmaceuticals. The Diagnostics segment includes the clinical laboratory operations of BioReference, as well as point-of-care operations. The Pharmaceuticals segment includes pharmaceutical operations in Chile, Mexico, Ireland, Israel, and Spain and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
OPK4795151
OPKO Health, Inc. 4.5% 15-FEB-2025
Yield to maturity
23.80%
Maturity date
Feb 15, 2025
OPK4048118
OPKO Health, Inc. 3.0% 01-FEB-2033
Yield to maturity
Maturity date
Feb 1, 2033
OPK4020628
OPKO Health, Inc. 3.0% 01-FEB-2033
Yield to maturity
Maturity date
Feb 1, 2033
OPK5733212
OPKO Health, Inc. 3.75% 15-JAN-2029
Yield to maturity
Maturity date
Jan 15, 2029

Explore more bonds 

Frequently Asked Questions


The current price of XCY is 1.55 EUR — it has decreased by −1.53% in the past 24 hours. Watch OPKO HEALTH INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange OPKO HEALTH INC stocks are traded under the ticker XCY.
XCY stock has risen by 11.63% compared to the previous week, the month change is a 14.92% rise, over the last year OPKO HEALTH INC has showed a 14.72% increase.
We've gathered analysts' opinions on OPKO HEALTH INC future price: according to them, XCY price has a max estimate of 7.87 EUR and a min estimate of 1.85 EUR. Watch XCY chart and read a more detailed OPKO HEALTH INC stock forecast: see what analysts think of OPKO HEALTH INC and suggest that you do with its stocks.
XCY reached its all-time high on Jun 1, 2015 with the price of 17.90 EUR, and its all-time low was 0.32 EUR and was reached on Jan 28, 2003. View more price dynamics on XCY chart.
See other stocks reaching their highest and lowest prices.
XCY stock is 5.93% volatile and has beta coefficient of 1.21. Track OPKO HEALTH INC stock price on the chart and check out the list of the most volatile stocks — is OPKO HEALTH INC there?
Today OPKO HEALTH INC has the market capitalization of ‪1.06 B‬, it has increased by 10.61% over the last week.
Yes, you can track OPKO HEALTH INC financials in yearly and quarterly reports right on TradingView.
OPKO HEALTH INC is going to release the next earnings report on Feb 20, 2025. Keep track of upcoming events with our Earnings Calendar.
XCY earnings for the last quarter are 0.03 EUR per share, whereas the estimation was −0.08 EUR resulting in a 132.14% surprise. The estimated earnings for the next quarter are −0.08 EUR per share. See more details about OPKO HEALTH INC earnings.
OPKO HEALTH INC revenue for the last quarter amounts to ‪155.92 M‬ EUR, despite the estimated figure of ‪163.04 M‬ EUR. In the next quarter, revenue is expected to reach ‪147.60 M‬ EUR.
XCY net income for the last quarter is ‪22.35 M‬ EUR, while the quarter before that showed ‪−9.62 M‬ EUR of net income which accounts for 332.36% change. Track more OPKO HEALTH INC financial stats to get the full picture.
No, XCY doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 16, 2024, the company has ‪3.93 K‬ employees. See our rating of the largest employees — is OPKO HEALTH INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. OPKO HEALTH INC EBITDA is ‪−188.07 M‬ EUR, and current EBITDA margin is −6.11%. See more stats in OPKO HEALTH INC financial statements.
Like other stocks, XCY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade OPKO HEALTH INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So OPKO HEALTH INC technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating OPKO HEALTH INC stock shows the neutral signal. See more of OPKO HEALTH INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.